To compare immunogenicity of HBV vaccine between 20 μg (0−1−6 month) and 60 μg (0−1 or 0−2 month) regimens in adults.
No differences in seroprotection rates among three vaccine groups at month 7/2/3 or 12.
The similar GMCs were observed in 20 μg (0−1−6 month) and 60 μg (0−2 month) groups at month 7/3.
A higher GMC level was induced by 3-dose (20 μg) HBV vaccine than by 2-dose (60 μg) at month 12.
All formulations of HBV vaccine were well tolerated with the incidence of adverse reactions <3%.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址:北京市海淀区学院路29号 邮编:100083 电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700 |